Immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during-treatment with a low-molecular-weight heparin (clivarin) in orthopedic patients

被引：0
|
作者：
Ahmad, S
Bacher, P
Lassen, MR
Hoppensteadt, DA
Leitz, H
Walenga, JM
Fareed, J
机构：
[1] Loyola Univ, Cardiovasc Inst, Maywood, IL 60153 USA
[2] Cent Hosp Hillerod, DK-3400 Hillerod, Denmark
来源：
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A205 / A205
页数：1
相关论文
共 50 条
  • [21] PLATELET-AGGREGATION INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN DURING ARDS
    ROYNARD, JL
    POURRIAT, JL
    LEROUX, G
    FOURNIER, JL
    CUPA, M
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1991, 10 (01): : 70 - 73
  • [22] Pre-existance of anti-platelet factor 4 heparin antibodies in patients not exposed to heparin or low molecular weight heparins. Relevance to clinical thrombocytopenia?
    Fareed, J
    Fabbrini, N
    Leitz, H
    Hoppensteadt, D
    BLOOD, 1996, 88 (10) : 2057 - 2057
  • [23] Cross-reactivity of low molecular weight heparin, their fractions and synthetic heparinomimetics with anti-platelet factor 4-heparin antibodies.
    Aldabbagh, A
    Ahmad, S
    Jeske, WP
    Walenga, JM
    Messmore, HL
    Cella, G
    Breddin, HK
    Fareed, J
    BLOOD, 1999, 94 (10) : 100B - 100B
  • [24] A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis
    Uncu, H.
    PHLEBOLOGY, 2009, 24 (02) : 56 - 60
  • [25] Differential Prevalence of Anti-Heparin-Platelet Factor 4 Antibodies In Elderly Patients with Acute Hip Fracture Undergoing Orthopaedic Surgery and Anticoagulated with Unfractionated Heparin and Enoxaparin
    Song, Christopher
    Cunanan, Josephine
    Kahn, Hussein
    Hoppensteadt, Debra
    Fareed, Jawed
    BLOOD, 2010, 116 (21) : 1714 - 1714
  • [26] About the effect of low-molecular-weight heparin on platelet function in haemodialysis patients
    Eleftheriadis, Theodoros
    Antoniadi, Georgia
    Liakopoulos, Vassilios
    Stefanidis, Ioannis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) : 1063 - 1064
  • [27] Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism
    Findik, S
    Erkan, ML
    Selçuk, MB
    Albayrak, S
    Atici, AG
    Doru, F
    RESPIRATION, 2002, 69 (05) : 440 - 444
  • [28] The effect of mobilization of patients during treatment of thromboembolic disorders with low-molecular-weight heparin
    Partsch, H
    Kechavarz, B
    Kohn, H
    Mostbeck, A
    INTERNATIONAL CONGRESS OF PHLEBOLOGY, 1996, : 283 - 289
  • [29] The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin
    Partsch, H
    Kechavarz, B
    Kohn, H
    Mostbeck, A
    INTERNATIONAL ANGIOLOGY, 1997, 16 (03) : 189 - 192
  • [30] Evolution of the platelet counts cardiopulmonary bypass in patients with antibodies to heparin-platelet 4 complexes and treated by unfractionated heparin or low-molecular weight heparin
    May, MA
    Pouplard, C
    Amiral, J
    Marchand, M
    Gruel, Y
    ANESTHESIOLOGY, 1998, 89 (3A) : U244 - U244
12345